A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

Tarec Christoffer El-Galaly¹, Verena I Gaidzik², Mihnea-Alexandru Gaman³, Darko Antic⁴, Jessica Okosun⁵, Mhairi Copland⁶, Veronika Sexl⁷, Adele K Fielding⁸, Robin Doeswijk⁹, Helen Parker⁹, Martin Dreyling¹⁰, Konstanze Döhner², António Medina Almeida^{11

12}, Elizabeth Macintyre^{13

14}, John G Gribben¹⁵, Kirsten Grønbæk^{16

17}

Affiliations

¹ Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
² Department of Internal Medicine III, University Hospital of Ulm, Germany.
³ Faculty of Medicine "Carol Davila" University of Medicine and Pharmacy Bucharest Romania & Department of Hematology Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
⁴ Clinic for Hematology, University Clinical Center of Serbia and Faculty of Medicine, University of Belgrade, Serbia.
⁵ Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom.
⁶ Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom.
⁷ Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
⁸ UCL Cancer Institute, London, United Kingdom.
⁹ European Hematology Association, EHA Executive Office, The Hague, The Netherlands.
¹⁰ Department of Medicine III, LMU Hospital, Munich, Germany.
¹¹ Department of Clinical Hematology, Hospital da Luz, Lisbon, Portugal.
¹² Faculdade de Medicina, Universidade Catolica Portuguesa, Lisbon, Portugal.
¹³ Université Paris Cité, CNRS, Inserm, INEM, F- 75015 Paris, France.
¹⁴ Hematology, AP-HP, Hôpital Necker-Enfants Malades, F- 75015 Paris, France.
¹⁵ Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom.
¹⁶ Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
¹⁷ Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

PMID: 36844176
PMCID: PMC9946429
DOI: 10.1097/HS9.0000000000000842

Editorial

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

Tarec Christoffer El-Galaly et al. Hemasphere. 2023.

. 2023 Feb 21;7(3):e842.

doi: 10.1097/HS9.0000000000000842. eCollection 2023 Mar.

Authors

Affiliations

¹ Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
² Department of Internal Medicine III, University Hospital of Ulm, Germany.
³ Faculty of Medicine "Carol Davila" University of Medicine and Pharmacy Bucharest Romania & Department of Hematology Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
⁴ Clinic for Hematology, University Clinical Center of Serbia and Faculty of Medicine, University of Belgrade, Serbia.
⁵ Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom.
⁶ Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom.
⁷ Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
⁸ UCL Cancer Institute, London, United Kingdom.
⁹ European Hematology Association, EHA Executive Office, The Hague, The Netherlands.
¹⁰ Department of Medicine III, LMU Hospital, Munich, Germany.
¹¹ Department of Clinical Hematology, Hospital da Luz, Lisbon, Portugal.
¹² Faculdade de Medicina, Universidade Catolica Portuguesa, Lisbon, Portugal.
¹³ Université Paris Cité, CNRS, Inserm, INEM, F- 75015 Paris, France.
¹⁴ Hematology, AP-HP, Hôpital Necker-Enfants Malades, F- 75015 Paris, France.
¹⁵ Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom.
¹⁶ Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
¹⁷ Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

PMID: 36844176
PMCID: PMC9946429
DOI: 10.1097/HS9.0000000000000842

No abstract available

PubMed Disclaimer

References

1. Brown DG, Wobst HJ, Kapoor A, et al. . Clinical development times for innovative drugs. Nat Rev Drug Discov. 2022;21:793–794. - PMC - PubMed
1. Stilgenbauer S, Eichhorst B, Schetelig J, et al. . Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet Oncol. 2016;17:768–778. - PubMed
1. DiNardo CD, Jonas BA, Pullarkat V, et al. . Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020;383:617–629. - PubMed
1. Neelapu SS, Locke FL, Bartlett NL, et al. . Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377:2531–2544. - PMC - PubMed
1. Ataga KI, Kutlar A, Kanter J, et al. . Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med. 2017;376:429–439. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

Affiliations

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

Authors

Affiliations

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources